Related Articles
Evaluation of the soluble fragments of cytokeratin 19 (CK19) in non-small cell lung cancer (NSCLC)
Comparison of Cyfra 21-1, TPA and SCC tumor markers in esophageal squamous cell carcinoma.
Prognostic and predictive value of CEA and CYFRA 21-1 levels in advanced non-small cell lung cancer patients treated with gefitinib or erlotinib
Decreased levels of serum cytokeratin 19 fragment CYFRA 21‑1 predict objective response to chemotherapy in patients with non-small cell lung cancer
CYFRA 21-1 - A NEW TUMOR-MARKER FOR LUNG-CANCER